Clarus Lifesciences II, L.P. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Clarus Lifesciences II, L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Clarus Lifesciences II, L.P.. Clarus Lifesciences II, L.P. is a 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and a 10% Owner in AERIE PHARMACEUTICALS INC ($AERI) and a 10% Owner in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and a 10% Owner in Blackstone Group L.P. ($BX) and a 10% Owner in NanoString Technologies Inc ($NSTG) and a 10% Owner in Ophthotech Corp. ($OPHT) and a 10% Owner in Restoration Robotics Inc ($HAIR) and a 10% Owner in CATABASIS PHARMACEUTICALS INC ($CATB).

Address: C/O CLARUS VENTURES, LLC 101 MAIN STREET, SUITE 1210 CAMBRIDGE 02142 MA

Companies in which Clarus Lifesciences II, L.P. is an Insider

ACHILLION PHARMACEUTICALS INC

Trading Symbol: ACHN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 3 shares
Current Value: $13
Latest Transaction: Jun 06 2012
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AERIE PHARMACEUTICALS INC

Trading Symbol: AERI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 30 2015
$AERI Market Capitalization: $1.50B
$AERI Previous Close: $42.80

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Blackstone Group Inc

Trading Symbol: BX
Industry: INVESTMENT ADVICE [6282]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,036,025 shares
Current Value: $62,200,564
Latest Transaction: Mar 22 2019
$BX Market Capitalization: $19.27B
$BX Previous Close: $30.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CATABASIS PHARMACEUTICALS INC

Trading Symbol: CATB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,752,488 shares
Current Value: $3,385,560
Latest Transaction: Jun 30 2015
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IVERIC bio, Inc.

Trading Symbol: OPHT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 28 2015
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NanoString Technologies Inc

Trading Symbol: NSTG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,036,025 shares
Current Value: $38,704,835
Latest Transaction: Mar 22 2019
$NSTG Market Capitalization: $400.76M
$NSTG Previous Close: $19.01

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TETRALOGIC PHARMACEUTICALS Corp

Trading Symbol: TLOG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,214,523 shares
Current Value: $132,871
Latest Transaction: Feb 10 2016
$TLOG Market Capitalization: $1.49M
$TLOG Previous Close: $0.06

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Venus Concept Inc.

Trading Symbol: VERO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 3,389,105 shares
Latest Transaction: Oct 17 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Clarus Lifesciences II, L.P.

Sentiment: All, ACHN, AERI, BX, CATB, OPHT, NSTG, TLOG, VERO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 22 2019NSTGNanoString Technol ...Clarus Lifesciences II, L.P.10% OwnerSellS21.622,000,00043,240,0002,036,0254 M to 2 M (-49.55 %)
Mar 22 2019BXBlackstone Group L ...Clarus Lifesciences II, L.P.10% OwnerSellS21.622,000,00043,240,0002,036,0254 M to 2 M (-49.55 %)
Sep 19 2018NSTGNanoString Technol ...Clarus Lifesciences II, L.P.10% OwnerOption ExerciseX8.45162,4081,372,0230
Sep 19 2018NSTGNanoString Technol ...Clarus Lifesciences II, L.P.10% OwnerOption ExerciseX8.45162,4081,372,0230
Sep 19 2018NSTGNanoString Technol ...Clarus Lifesciences II, L.P.10% OwnerSellS15.9985,8231,372,3104,036,0254.1 M to 4 M (-2.08 %)
Sep 19 2018NSTGNanoString Technol ...Clarus Lifesciences II, L.P.10% OwnerSellS15.9985,8231,372,3104,036,0254.1 M to 4 M (-2.08 %)
Sep 19 2018NSTGNanoString Technol ...Clarus Lifesciences II, L.P.10% OwnerBuyX8.45162,4081,372,0234,121,8484 M to 4.1 M (+4.10 %)

View all Clarus Lifesciences II, L.P. insider transactions.